BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chunyk AG, Joyce A, Fischer SK, Dysinger M, Mikulskis A, Jeromin A, Lawrence-henderson R, Baker D, Yeung D. A Multi-site In-depth Evaluation of the Quanterix Simoa from a User’s Perspective. AAPS J 2018;20. [DOI: 10.1208/s12248-017-0156-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Lee J, Kane BJ, Khanwalker M, Sode K. Development of an electrochemical impedance spectroscopy based biosensor for detection of ubiquitin C-Terminal hydrolase L1. Biosens Bioelectron 2022;208:114232. [PMID: 35390718 DOI: 10.1016/j.bios.2022.114232] [Reference Citation Analysis]
2 Song T, Wang G, Ding M, Rodriguez-Paton A, Wang X, Wang S. Network-Based Approaches for Drug Repositioning. Mol Inform 2021;:e2100200. [PMID: 34970871 DOI: 10.1002/minf.202100200] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
3 Hazan J, Alston D, Fox NC, Howard R. Practical application of Alzheimer's Disease Neuroimaging Initiative plasma P-tau181 reference data to support diagnosis of Alzheimer's disease. Int J Geriatr Psychiatry 2021;37. [PMID: 34997780 DOI: 10.1002/gps.5670] [Reference Citation Analysis]
4 Krausz AD, Korley FK, Burns MA. The Current State of Traumatic Brain Injury Biomarker Measurement Methods. Biosensors (Basel) 2021;11:319. [PMID: 34562909 DOI: 10.3390/bios11090319] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
5 Darlix A, Hirtz C, Mollevi C, Ginestet N, Tiers L, Jacot W, Lehmann S. Serum glial fibrillary acidic protein is a predictor of brain metastases in patients with metastatic breast cancer. Int J Cancer 2021;149:1605-18. [PMID: 34196964 DOI: 10.1002/ijc.33724] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
6 Wang BZ, Wang MJ, Wang MR, Ou L, Dong LH, Dong K, Song HF. Development and Validation of a Simoa Assay for Determination of Recombinant Batroxobin in Human Serum. Curr Med Sci 2021;41:618-25. [PMID: 34169424 DOI: 10.1007/s11596-021-2382-6] [Reference Citation Analysis]
7 Lasseter HC, Provost AC, Chaby LE, Daskalakis NP, Haas M, Jeromin A. Cross-platform comparison of highly sensitive immunoassay technologies for cytokine markers: Platform performance in post-traumatic stress disorder and Parkinson's disease. Cytokine X 2020;2:100027. [PMID: 33604555 DOI: 10.1016/j.cytox.2020.100027] [Cited by in Crossref: 4] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
8 Kim SE, Tieu MV, Hwang SY, Lee MH. Magnetic Particles: Their Applications from Sample Preparations to Biosensing Platforms. Micromachines (Basel) 2020;11:E302. [PMID: 32183074 DOI: 10.3390/mi11030302] [Cited by in Crossref: 13] [Cited by in F6Publishing: 18] [Article Influence: 6.5] [Reference Citation Analysis]
9 Sperinde G, Hokom M, Peng K, Fischer SK. Bioanalytical challenges in development of ultrasensitive Home Brew assays: a case study using IL-13. Bioanalysis 2019;11:1045-54. [PMID: 31251105 DOI: 10.4155/bio-2019-0012] [Reference Citation Analysis]
10 Ng ASL, Tan YJ, Lu Z, Ng EYL, Ng SYE, Chia NSY, Setiawan F, Xu Z, Tay KY, Prakash KM, Au WL, Tan EK, Tan LCS. Plasma alpha-synuclein detected by single molecule array is increased in PD. Ann Clin Transl Neurol 2019;6:615-9. [PMID: 30911585 DOI: 10.1002/acn3.729] [Cited by in Crossref: 13] [Cited by in F6Publishing: 21] [Article Influence: 4.3] [Reference Citation Analysis]
11 Huynh T, Byrnes SA, Chang TC, Weigl BH, Nichols KP. General methods for quantitative interpretation of results of digital variable-volume assays. Analyst 2019;144:7209-19. [DOI: 10.1039/c9an01479a] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]